1 May 2026 - The May 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The May issue of the Schedule includes has many new/revised listings of note:

• Calcipotriol monohydrate with betamethasone valerate (Actobet) - New formulation
• Glycopyrronium bromide (Axhidrox) - new indication
• Fruquitinib (Fruzaqla) - new medicine

Read summary of PBS changes